• Direct Treatment Costs Of Stroke In Turkey

    Nov 1, 2015, 00:00

  • Delays in Diagnosis of Breast Cancer in Gree Findings from a Qualitative Study

    Nov 1, 2015, 00:00

  • A Decision Options Approach to Antibiotic RD Investment

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Canacinumab In The Treatment of Patients With Muckle–Wells Syndrome In The Russian Federation

    Nov 1, 2015, 00:00

  • Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de La Gasa Sintética Frente a la Gasa de Algodón de Pieza Única En El Manejo de Heridas en Colombia

    Nov 1, 2015, 00:00

  • Steering vaccines through the uk system - what factors influence the likelihood of positive and negative recommendations?

    Nov 1, 2015, 00:00

  • Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions

    Nov 1, 2015, 00:00

  • Willingness to Pay for Quality-Adjusted Life Years In Patients With Diabete

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece

    Nov 1, 2015, 00:00

  • Mortality In A University Pediatric Hospital In Colombia 2000 – 2014

    Nov 1, 2015, 00:00

  • The Impact Of New Endovascular Therapies For Femoropopliteal Arterial Disease On Therapy Utilization And Case Volumes In Germany, 2009-2013

    Nov 1, 2015, 00:00

  • Occurrence of Treatment Interruption During Therapy with Biological Agents in Patients with Previous Anti-Tnf Failure in Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Analysis of the Reports of the National Committee for Technology Incorporation (Conitec) in the Brazilian Public Health System (Sus), 2012-2015

    Nov 1, 2015, 00:00

  • French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours- Perspective For Future Trends

    Nov 1, 2015, 00:00

  • Using An Economic Model To Choose Initial Appropriate Antibiotic Therapy Based On Differences In In-Vitro Susceptibility To Ceftolozane/Tazobactam And Piperacillin/Tazobactam

    Nov 1, 2015, 00:00

  • Methodology of International Comparison of Pharmaceutical Prices

    Nov 1, 2015, 00:00

  • Impact of Grexit on Pharmaceutical Pricing- An International Reference Pricing Analysis

    Nov 1, 2015, 00:00

  • Costo-Efectividad Del Desfibrilador Externo Automático (Dea) Comparado Con Reanimación Cardiopulmonar Básica (Rcp) En Colombia

    Nov 1, 2015, 00:00

  • The Cumulative Analysis of Checklist Questionnaires Filled Out by the Hungarian HTA Office

    Nov 1, 2015, 00:00

  • A Comparison of Time to Launch and Reimbursement for New Medicines across Developed Countries

    Nov 1, 2015, 00:00

  • Modelling Health Benefits Associated to Early Diagnosis and Treatment of Copd

    Nov 1, 2015, 00:00

  • Biosimilars- Accessing the Uk Market

    Nov 1, 2015, 00:00

  • Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation

    Nov 1, 2015, 00:00

  • Understanding Local Commissioning Decisions on New Pharmacotherapies In The Uk

    Nov 1, 2015, 00:00

  • Reference Pricing For Laboratory Tests In The United States- Impact On Prices And Spending

    Nov 1, 2015, 00:00

  • Resource Utilisation And Costs In Patients With Post-Stroke Spasticity In The United Kingdom

    Nov 1, 2015, 00:00

  • Comparison of Bazedoxifene/Conjugated Oestrogens Vs Current Therapies in the Treatment of Postmenopausal Symptoms- Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Costos económicos de la otitis media aguda. Una revisión de la literatura

    Nov 1, 2015, 00:00

  • Prevalence Of Chronic Kidney Disease In India- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Using Financial Incentives to Motivate Stair Use In A Workplace Setting- Results From A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Assessing Japan’s Three Early Access Programs Based On Recent Discussions- Scope And Financial Aid

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

    Nov 1, 2015, 00:00

  • condition Specific Utilities- Impact on Icer in a Markov Model for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Trends In Self-Rated Health Status Among Adults In Greece (2002-2015)

    Nov 1, 2015, 00:00

  • Análisis de Costo-Efectividad de Inyeccion Intravitrea de Ranibizumab Versus Aflibercept en el Tratamiento de la Perdida Visual Secundaria a Edema Macular Diabetico Desde la Perspectiva del Sistema de Salud en Colombia

    Nov 1, 2015, 00:00

  • Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal

    Nov 1, 2015, 00:00

  • Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients

    Nov 1, 2015, 00:00

  • Innovation Ranking in France and Italy- Differences and their Impact on Pricing and Reimbursement Processes

    Nov 1, 2015, 00:00

  • Dispensing of The Combination of Amoxicillin With Clavulanic Acid to Elderly Patients- A Database Analysis

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in Treatment and Secondary Prevention of Venous Thromboembolism (Vte) in Patients with Deep Vein Thrombosis (Dvt)

    Nov 1, 2015, 00:00

  • Cytogenetics And Dopamine Receptor (Drd2) Gene Polymorphism In Schizophrenia Patients

    Nov 1, 2015, 00:00

  • Patient Diagnostic Therapeutic Pathway For Patients With Psoriasis The Organisational Analysis of 13 Excellence Centres Of The Tuscany Region (Italy)

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis In The Italian Setting

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Guideline for Positive Drug List Application Purposes Implemented In Bulgaria

    Nov 1, 2015, 00:00

  • Medical Care And Costs of Patients With Systemic Lupus Erythematosus In Taiwan

    Nov 1, 2015, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Advanced Melanoma In Portugal

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Secukinumab Compared to Ustekinumab In Patients With Psoriasis From A Swedish Health Care Perspective

    Nov 1, 2015, 00:00

  • Cardiovascular Event Rates in a High-Risk General Population Cohort of 340,000 Individuals in the United Kingdom

    Nov 1, 2015, 00:00

  • Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Opioid Substitution Treatment in Slovenia

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Treatment For Chronic Heart Failure- A Systematic Review

    Nov 1, 2015, 00:00

  • Effects Of Lifestyle Interventions On Body Mass Index In Breast Cancer Patients

    Nov 1, 2015, 00:00

  • The Burden of Obesity in Mexico- Prevalence, Comorbidities, and Associations With Quality of Life, Resource Utilization and Productivity

    Nov 1, 2015, 00:00

  • Evaluaci”N De La Prescripci”N Medica De Antihipertensivos En Los Médicos Cardi”Logos Del Hospital Nacional Edgardo Rebagliati Martins, Lima (Peru)

    Nov 1, 2015, 00:00

  • Determinantes y Barreras Socioeconómicas del Acceso A Los Servicios de Salud en Las Regiones de Colombia

    Nov 1, 2015, 00:00

  • Survival And Cost Among Photodynamic Therapy Patients With Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • A Pilot Study Measuring Knowledge and Attitudes Towards Diabetes Mellitus In Kedah, Malaysia

    Nov 1, 2015, 00:00

  • Patient Profile of New Users of Novel Oral Anticoagulants in non-Valvular Atrial Fibrillation (Nvaf)- Real-World Evidence from Primary Care Data in Germany

    Nov 1, 2015, 00:00

  • Preferences for Using Phone Calls, Text Messaging, and Email to Communicate with Physicians Among Patients with four chronic diseases

    Nov 1, 2015, 00:00

  • Medication Adherance and Satisfaction With Treatment In Patients With Diabetes Mellitus Receiving Oral Combination Therapy- Data of A Real-World Study

    Nov 1, 2015, 00:00

  • The Indirect Costs of Inflammatory Bowel Disease (Crohn’s Disease And Ulcerative Colitis) Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00

  • Decision-Analytic Modeling Studies- An Overview for Clinicians Using Dlbcl As An Example

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service

    Nov 1, 2015, 00:00

  • New Copd Medicinal Products Entrance Analysis And Their Influence On The Number And Cost Of Hospitalizatons Due To Copd Exacerbations

    Nov 1, 2015, 00:00

  • The Impact of Societal Views on Market Access- Case Studies For Utilization of Hpv Vaccines in Cervical Cancer and Prep Hiv Preventive Therapy

    Nov 1, 2015, 00:00

  • Outcome of Harkány Thermal Water Completed Puva Therapy Versus Traditional Puva Therapy of Psoriatic Patients

    Nov 1, 2015, 00:00

  • How Do we Estimate Quality Adjusted Life Years (Qalys) in Rare Diseases? A Case Study in Hypophosphatasia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

    Nov 1, 2015, 00:00

  • Qualitative and Quantitative Analysis of The Scottish Medicines Consortium (Smc) Advice

    Nov 1, 2015, 00:00

  • Blood Glucose Test Result From Employees At Health Clinic of Songino Khairkhan District

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation

    Nov 1, 2015, 00:00

  • The Research on The Relationship Between The Ovarian Function Damage With Fluorosis and The Protective Effect of Selenium

    Nov 1, 2015, 00:00

  • Study on Quality of Nursing Care and Assessment of Safety

    Nov 1, 2015, 00:00

  • Budget Impact of Perampanel for The Treatment of Patients With Partial-Onset Seizures (Pos) In Russia

    Nov 1, 2015, 00:00

  • Mobile Phone Use And Willingness To Pay For Sms For Diabetes In Bangladesh

    Nov 1, 2015, 00:00

  • Economic Evaluation For The Rapid Test Dpp® Hiv-Syphilis Assay With Immunochromatography In Pregnant Women In Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

    Nov 1, 2015, 00:00

  • Healthcare Use and Expenditure for Diabetes In Bangladesh- A Matched-Case-Control Study

    Nov 1, 2015, 00:00

  • A Framework for Prioritizing Research Investments in Precision Medicine

    Nov 1, 2015, 00:00

  • A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Anidulafungin, Micafungin, Caspofungin And Fluconazole In The Treatment Of Candidemia And/Or Invasive Candidiasis In Non-Neutropenic Adult Patients In Spain

    Nov 1, 2015, 00:00

  • Opportunities with Accelerated Approval Times, but Stumbles at Hta? the Impact of a Limited Evidence Package

    Nov 1, 2015, 00:00

  • Effectiveness Of The St2 For Prognosis In Heart Failure- Systematic Reviews

    Nov 1, 2015, 00:00

  • Cost Analysis of Proton Pump Inhibitors In The Treatment of Gastroesophageal Reflux Disease In Ukraine

    Nov 1, 2015, 00:00

  • Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile

    Nov 1, 2015, 00:00

  • Are Vaccinations Really Different to Pharmaceuticals With Respect to Market Access In Germany?

    Nov 1, 2015, 00:00

  • Use of Quality of Care (Qoc) Metrics Among Oncologists In the United States (Us)

    Nov 1, 2015, 00:00

  • Economic Impact of Expanded Use of Biologic Therapy for Crohn’s Disease In Latin American Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Pregabalin In The Treatment of Central Neuropathic Pain

    Nov 1, 2015, 00:00

  • Cancer Is Associated With Intraoperative And Postprocedural Complications And Disorders

    Nov 1, 2015, 00:00

  • Development Of A Web-Based Quality Of Life Portal For Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Impact of Hta – an Irish Case Study

    Nov 1, 2015, 00:00

  • Health Services Utilization By Dengue Patient In Brazil, 2012 – 2013- A Multicenter Study

    Nov 1, 2015, 00:00

  • Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children- A Systematic Review

    Nov 1, 2015, 00:00

  • A Systematic Review of Economic Evaluations in Latin America- Assessing the Factors that affect Adaptation and Transferability of Results

    Nov 1, 2015, 00:00

  • Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)

    Nov 1, 2015, 00:00

  • Newer Antiepileptic Drugs Dispensed By Community Pharmacies- Generic Prescribing and Cost

    Nov 1, 2015, 00:00

  • Long-Term Trends In Descriptive Epidemiology Of Malignant Melanoma In The Slovak Republic

    Nov 1, 2015, 00:00

  • Exploring Attitudes and Perceptions of Patients and Staff Towards a Fee For Service “After Hours” Clinic Supplementing Free Hiv Services in Uganda- A Qualitative Study

    Nov 1, 2015, 00:00

  • Decision Drivers in Health Technology Assessment in Hepatitis C

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review

    Nov 1, 2015, 00:00

  • Economic Burden Of Acute Myocardial Infarction In Vietnam

    Nov 1, 2015, 00:00

  • Health Technology Assessment Practices In Turkey

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Rivaroxabán Como Profilaxis En Cirugía De Reemplazo Total De Cadera Y/O De Rodilla Frente A Enoxaparina, En Colombia

    Nov 1, 2015, 00:00

  • A Retrospective Analysis of Time to Market Access and the Regional Impact of Spanish ‘Place in Therapy’ Reports

    Nov 1, 2015, 00:00

  • Epidemiology of Patients Affected by Acute Coronary Syndrome (Acs) Treated with Statins for Hypercholesterolemia from Italian Administrative Official Databases

    Nov 1, 2015, 00:00

  • Development and Validation of A Patient-Reported Outcome Measure of the Psychological Impact of Submental Fat

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Bladder Cancer- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, From The Spanish Nhs Perspective

    Nov 1, 2015, 00:00

  • Mortality Rate and Premature Mortality Due to Systemic Erythematosus Lupus (Sle) in Latin America, Us and England and Wales

    Nov 1, 2015, 00:00

  • Methotdological Difficulties Of Compliance Analyses Based On Real-World Data

    Nov 1, 2015, 00:00

  • Aumento del Riesgo de Cancer por Efecto de Variaciones Acumuladas en la Exposici”n a la Radiacion en Estudios de Radiología Convencional y Tomografía Computarizada en Pacientes Pediátricos

    Nov 1, 2015, 00:00

  • How Can Biosimilars Compete with Existing Biologics- update of the Results of a Previous Study

    Nov 1, 2015, 00:00

  • Identifying Research Gaps in Antimicrobial Resistance (Amr)- Literature Review, Potential Research Questions and Study Designs

    Nov 1, 2015, 00:00

  • Changes In The Prices Of Reference Biotechnology Products By The Penetration Of Biosimilars Into The Turkish Pharmaceutical Market

    Nov 1, 2015, 00:00

  • Antipsychotic Exposure And Risk of Stroke- A Systematic Review And Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – A Health Technology Assessment

    Nov 1, 2015, 00:00

  • Measuring Post-Partum Hemorrhage In Low-Resource Settings- The Diagnostic Validity Of Weighted Blood Loss Versus Quantitative Changes In Hemoglobin

    Nov 1, 2015, 00:00

  • The Use Of Real World Evidence To Support Market Access Of Medical Devices – Implications For The German Setting

    Nov 1, 2015, 00:00

  • An Evaluation of a New Regional Decision making Process in Sweden for High-Cost Hospital Therapies

    Nov 1, 2015, 00:00

  • Developing A Drug Price Reference Index In The Philippines

    Nov 1, 2015, 00:00

  • The Relationship Between Socioeconomic Characteristics And Self-Rated Health In Greece

    Nov 1, 2015, 00:00

  • Does A New Pharmacoeconomic Model Is Demanded for Obesity’s Pharmacotherapy Assessment?

    Nov 1, 2015, 00:00

  • A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

    Nov 1, 2015, 00:00

  • Opioids Switch In Chronic Pain- Impact Assessment Using Electronic Health Records

    Nov 1, 2015, 00:00

  • Longitudinal Changes in Medical Services Costs from 2006 to 2012 for Newly Diagnosed T2D Patients

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Heart Failure Patients- Health Utilities And Predictive Determinants

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Chemotherapy Regimen In Metastatic Breast Cancer Egyption Prospective

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium Administrated Through The Respimat Inhaler As Add-On Therapy In Patients With Uncontrolled Severe Asthma In Poland

    Nov 1, 2015, 00:00

  • Usability Testing of an Integrated Glucometer and Handheld Electronic Patient-Reported Outcome System

    Nov 1, 2015, 00:00

  • Meta-Analysis to Support Technology Submissions to Health Technology Assessment Authorities- Criticisms By Nice And Evidence Review Groups in the Uk

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

    Nov 1, 2015, 00:00

  • Costs of Adverse Drug Events- Systematic Review

    Nov 1, 2015, 00:00

  • Preference Elicitation On Benefits And Risks Of Medicines Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in Portugal

    Nov 1, 2015, 00:00

  • Risk Factors and Causes of Intrauterine Death

    Nov 1, 2015, 00:00

  • Custo-Efetividade Da Cintilografia Óssea De Corpo Inteiro Na Avaliação Pre-Transplante Hepático De Pacientes Com Carcinoma Hepatocelular Na Região Sul Do Brasil

    Nov 1, 2015, 00:00

  • Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use- Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)

    Nov 1, 2015, 00:00

  • Decrease of Patient Costs in the Netherlands- a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc)

    Nov 1, 2015, 00:00

  • Ankylosing Spondylitis Treatment and Follow-Up Costs in Colombia

    Nov 1, 2015, 00:00

  • Field Monitoring Of The Z Benefits For Breast Cancer Of The Philippine Health Insurance Corporation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service

    Nov 1, 2015, 00:00

  • Can Advances in Health Monitors Lead to Health Being Looked at as A Commodity?

    Nov 1, 2015, 00:00

  • Inflation, Inflexibility and Irrelevance – the Need for Inflation to be Accounted for in Icer Thresholds

    Nov 1, 2015, 00:00

  • Economic Evaluation for The Decision Making Process of Implementing of Pharmaceutical Care for The Treatment of Hypertension In The Brazilian Health System- Stage I - Direct-Costs Analysis

    Nov 1, 2015, 00:00

  • Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Mental Health Disorder Prevalence Trends In Germany- A Longitudinal Analysis

    Nov 1, 2015, 00:00

  • Regulations of The German Drug Market

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy

    Nov 1, 2015, 00:00

  • Relationship Between Non Compliance to Claim Medication in Pharmacy and Incidence of Hospitalizations in Patients with Breast Cancer

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Model Evaluating Component-Resolved Diagnosis (Crd) Versus Standard Testing Method (Skin Prick Testing (Spt)) In The Diagnosis And Treatment of Allergic Rhinitis In The Netherlands

    Nov 1, 2015, 00:00

  • Comparison of Cost of Treatment of Selected Cancers with Patented Drugs- India Versus its Neighbors

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium For Severe Persistent Asthma In Portugal

    Nov 1, 2015, 00:00

  • Resource Utilization And Treatment Costs Of Stroke In Patients With Non-Valvular Atrial Fibrillation In Spain

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Glucose Monitoring Devices

    Nov 1, 2015, 00:00

  • Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

    Nov 1, 2015, 00:00

  • Comparison between HTA Reports in Veneto and Emilia Romagna- Drugs Assessment Decision Criteria and Priorities

    Nov 1, 2015, 00:00

  • Physicians’ Choice As A Comparator In Clinical Trials- Challenges for Pharmacoeconomic Modelling of Innovative Treatments to Support Health Technology Assessments

    Nov 1, 2015, 00:00

  • Modeling The Burden of Abdominal Aortic Aneurysm (Aaa) In Europe In 2013

    Nov 1, 2015, 00:00

  • Economic and Humanistic Burden of Ductal Carcinoma in Situ

    Nov 1, 2015, 00:00

  • Economic Evaluation of Ulipristal Acetate For The Treatment of Patients With Moderate And Severe Symptoms of Uterine Fibroids Before Surgery In Mexico

    Nov 1, 2015, 00:00

  • Associated Factors The Virologic Success In A Group of Patients With Human Immunodeficiency Virus, Managed By A Care Team Integral, Eps|Sura Medellin 2010-2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pen Devices For Nph Insulin Administration Compared With Syringe And Vial In Adult Patients With Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00

  • Cost Implications of Further Limiting or Increasing Generic Prescribing of Antiepileptics In English And Welsh General Practices

    Nov 1, 2015, 00:00

  • Orphan Drug Regulation In The Usa, European Union, Japan and South Korea- A Comparative Analysis

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Geriatric Diabetics in a Tertiary Care Hospital- A Prospective Study

    Nov 1, 2015, 00:00

  • New Possibility for Testing The Dynamic Stability of The Trunk and Lower Extremities

    Nov 1, 2015, 00:00

  • Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

    Nov 1, 2015, 00:00

  • The United States Specialty Pharmacy Payor Landscape

    Nov 1, 2015, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead to Unintended Harm of Ireland’s Health System?

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia

    Nov 1, 2015, 00:00

  • Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

    Nov 1, 2015, 00:00

  • Cost Comparison of Oral Versus iv Vinorlbine in France in Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Comparação De Custos E Efetividade Entre Ml- Flow E Baciloscopia Para Auxílio Diagn”Stico E Tratamento Da Hanseníase

    Nov 1, 2015, 00:00

  • Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

    Nov 1, 2015, 00:00

  • Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

    Nov 1, 2015, 00:00

  • The Effect of Positioning The Lower Extremities on Postoperative Bleeding After Total Knee Replacement

    Nov 1, 2015, 00:00

  • Reducing The Barriers To Capturing Patient Reported Outcomes In Oncology Studies

    Nov 1, 2015, 00:00

  • Trends in Hospital Standardized Mortality Ratios in Japan

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de Un Paquete de Tres Torundas de Algodón Estériles Frente a Toallas Impregnadas Con Solución Antiséptica Como Estrategia de Antisepsia en Venopunción

    Nov 1, 2015, 00:00

  • The Role of Education In The Management of Type 1 Diabetes Mellitus In England

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of A Genomic Test Compared To Standard Of Care In Breast Cancer Patients In France

    Nov 1, 2015, 00:00

  • Development Of Medical And Technological Documents On Standardization Of Medical Care In Cardiovascular Diseases In Ukraine

    Nov 1, 2015, 00:00

  • Utilizacion De Antibacterianos De Uso Restringido En Pacientes Adultos Hospitalizados En El Hospital Las Higueras - Talcahuano

    Nov 1, 2015, 00:00

  • International Differences in the Role of Payer and Administrative Controls in Prescribing Decisions

    Nov 1, 2015, 00:00

  • Machine Learning For Identifying Potentially Undiagnosed Post-Stroke Spasticity Patients In United Kingdom

    Nov 1, 2015, 00:00

  • Comparison of Pharmaceutical Pricing and Reimbursement Systems In Turkey And Certain Other Eu Countries

    Nov 1, 2015, 00:00

  • Determinant Factors of the Administrative Pathway to Access Medicines in the Brazilian Health System

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Long-Acting Insulin Analogues in the Perspective of Brazilian Public Health System

    Nov 1, 2015, 00:00

  • To Study The Clinical Characteristics, Treatment Pattern And Factors Associated With The Total Hospital Cost In Acute Respiratory Distress Syndrome In Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Using Machine Learning Techniques To Classify Oecd Countries According to Health Expenditures

    Nov 1, 2015, 00:00

  • Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Bra A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies

    Nov 1, 2015, 00:00

  • Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

    Nov 1, 2015, 00:00

  • Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practi German Base Case

    Nov 1, 2015, 00:00

  • Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective

    Nov 1, 2015, 00:00

  • Uso de recursos y costos relacionados al tratamiento de complicaciones de la diabetes mellitus tipo 2 (dmt2) en colombia. Una estimacion basada en guias de practica clinica (gpc)

    Nov 1, 2015, 00:00

  • The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil

    Nov 1, 2015, 00:00

  • Prices of Pharmaceuticals Under a Generic Price Linkage System And a Reference Price System- Comparison of Austria and Finland

    Nov 1, 2015, 00:00

  • Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Cost and Cost-Effectiveness Data on Pancreatic Cancer- a Comprehensive Review of the Literature

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Barriers To Participation In Trials Of Cancer- A Survey On Clinical Research Perception

    Nov 1, 2015, 00:00

  • Representing the Threshold in the Cost-Effectiveness Plane- Proposing a New Graphical Convention

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Chronic Hcv Gt1 Drugs in Poland

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for Colombian Health System

    Nov 1, 2015, 00:00

  • Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events- a Large United States Real World Study

    Nov 1, 2015, 00:00

  • Tratamiento Ambulatorio Versus Hospitalario Relacionado A Agudizaciones En Pacientes Con Asma Desde Una Perspectiva Institucional Publica Mexicana

    Nov 1, 2015, 00:00

  • Conflicts’ Mediation Between Consumers and Health Plans- The Usage Profile of The Available Channels for Complaints

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson’S Disease

    Nov 1, 2015, 00:00

  • The Analysis of Telemedicine Technologies In Pediatric Patients

    Nov 1, 2015, 00:00

  • There Is Evidence of Increased Risk of Cancer In Patients Using Human Insulin Analogue Glargine For Treatment of Diabetes Mellitus - Overview Based Evaluation

    Nov 1, 2015, 00:00

  • Association Between Depression And Discontinuation With Antidiabetic Drugs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Longevity In Portugal, 2002–2010

    Nov 1, 2015, 00:00

  • First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d

    Nov 1, 2015, 00:00

  • Implant Versus Oral Contraception Use- 3-Years Budget Impact Analysis for the National Heal System in Portugal

    Nov 1, 2015, 00:00

  • Burden Of Symptomatic Copd Patients In Spain- Data From Continuing To Confront Copd International Patient Survey 2012-2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program- A Dynamic Model-Based Analysis

    Nov 1, 2015, 00:00

  • Patients Experience At Hospital Discharge and Readmissions

    Nov 1, 2015, 00:00

  • A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos)

    Nov 1, 2015, 00:00

  • Delay Of Optimal Nocturia Treatment Is Costly- Results Of A Real World Survey Of Patients In Europe And The Usa

    Nov 1, 2015, 00:00

  • The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Are Qalys An Appropriate Measure To Use When Evaluating Public Health Interventions In The Uk?

    Nov 1, 2015, 00:00

  • Economic Modelling Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Role Of Budget Impact Analysis In Market Access Of Biosimilars

    Nov 1, 2015, 00:00

  • Analysis of The Cost of Invasive Fungal Infections In Patients With Hemopoetic Stem Cell Transplantation

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Cardio-Desfibrilador Implantable Comparado Con La Terapia Farmacológica Optima Para El Tratamiento De Los Pacientes Con Falla Cardiaca En Colombia

    Nov 1, 2015, 00:00

  • The Use of Real World Data to Build Economic Models- A Case Study of Osteoporosis

    Nov 1, 2015, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary In Case Of Erythropoietin Products

    Nov 1, 2015, 00:00

  • Search for Clinically and Economically Effective Lymphomas Treatment

    Nov 1, 2015, 00:00

  • Practices of Substance Abuse and Risky Sexual Behavior Among Adama Science and Technology University Undergraduate Students in 2012/13 Academic Years

    Nov 1, 2015, 00:00

  • A Perspective on the use of Health Technology Assessment in Brazil and Mexico

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Access to Biologics for Rheumatoid Arthritis in the Public Sector of a Latam Country

    Nov 1, 2015, 00:00

  • The Rheumatologist’s Perspective In Diagnostic Course and Management of Familial Mediterranean Fever

    Nov 1, 2015, 00:00

  • Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden

    Nov 1, 2015, 00:00

  • PATIENT CHARACTERISTICS AND HEALTHCARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES

    Nov 1, 2015, 00:00

  • Characterization of Osteoporosis In Portugal - Treatment Patterns And Reasons for Under-Treatment and Non-Persistence With Pharmacological Treatments

    Nov 1, 2015, 00:00

  • An Analysis Of Drivers Of Positive And Negative Appraisals By Nice’s Medical Technology Evaluation Programme (Mtep)

    Nov 1, 2015, 00:00

  • Pharmacovigilance in Oncology- Knowledge and Perception on Adverse Events Reporting in Brazil

    Nov 1, 2015, 00:00

  • Assessing The Level Of Resistance/Intolerance To Hydroxyurea Therapy Amongst Patients With Polycythemia Vera In Europe

    Nov 1, 2015, 00:00

  • Does Out-Patient Medical Insurance Policy Work Among Ckd Patients In Non-Dialysis Phases? Evidence From Two Sample Cities In China

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Trastuzumab-Emtansine Para El Manejo De Pacientes Con Cáncer De Mama Her2 Positivo Avanzado Con Tratamiento Previo Con Trastuzumab Y Un Taxano Por Separado O En Combinación, Para Venezuela

    Nov 1, 2015, 00:00

  • Does use of calcium channel blockers affect the risk of incident active tuberculosis disease? A nested case control study on a national health claim database

    Nov 1, 2015, 00:00

  • New Drugs In Advanced Melanoma- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento De La Drepanocitosis En Colombia, Desde La Perspectiva Del Uso De Servicios De Salud

    Nov 1, 2015, 00:00

  • The Epipen4schools® Survey- Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

    Nov 1, 2015, 00:00

  • Costo De Cáncer Gástrico Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00

  • Systematic Review Of Productivity Losses Associated With Cardiovascular Disease In Europe

    Nov 1, 2015, 00:00

  • Work Capacity And Health Status Test of Police Officers

    Nov 1, 2015, 00:00

  • Increased Costs Due To Myocardial Infarction (Mi) In Fran An Observational Analysis Using A Claims Database

    Nov 1, 2015, 00:00

  • Possible Applications of Real World Evidence in Safety Operations

    Nov 1, 2015, 00:00

  • Societal and Non-Healthcare Costs Associated With Atypical Haemolytic Uraemic Syndrome In The Uk- Results of A Patient Survey

    Nov 1, 2015, 00:00

  • Streamlining The Access Decision Process For German Patients to Receive Reimbursed Treatments In Another European Union Member State

    Nov 1, 2015, 00:00

  • Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Economic Burden of Chronic Spontaneous Urticaria And Psoriasis- Patients Perspective From Europe

    Nov 1, 2015, 00:00

  • Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers- Patterns of Treatment and Costs

    Nov 1, 2015, 00:00

  • The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada

    Nov 1, 2015, 00:00

  • Análisis De Costo Efectividad Del Uso De Sorafenib En Pacientes Con Carcinoma Hepatocelular En Estadios Avanzados, Para El Contexto Ecuatoriano

    Nov 1, 2015, 00:00

  • Costo De Cáncer De Cuello Uterino En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US

    Nov 1, 2015, 00:00

  • Economic Evaluations of Treatments for Inflammatory Bowel Diseases

    Nov 1, 2015, 00:00

  • Systematic Literature Review And Critical Appraisal Of The Suitability Of The Outcome Measures Used In The Idiopathic Pulmonary Fibrosis

    Nov 1, 2015, 00:00

  • Observational (Obs), Pragmatic (Pra), And Indirect (Ind) Methodologies For Comparative Relative Effectiveness (Re) And Benefit-Risk (Br) Analyses

    Nov 1, 2015, 00:00

  • Proton Pump Inhibitors In Italy- It’s Time to Make A (Policy) Change

    Nov 1, 2015, 00:00

  • Pharmacoeconomical Characteristics of Different Strategies of Hemostasis During Extensive Hepatectomy

    Nov 1, 2015, 00:00

  • Economic Benefits Of Endometrial Radiofrequency Ablation Compared With Other Endometrial Ablation Techniques In Women With Menorrhagia- A Retrospective Analysis With German Health Claims Data

    Nov 1, 2015, 00:00

  • The Atlantic Divide In Coronary Heart Disease- Health Technologies Use In The Us And Portugal

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

    Nov 1, 2015, 00:00

  • Resource And Cost Savings Due To Subcutaneous Versus Intravenous Administration Of Oncology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Patients’ Perception of Adherence to Therapy In Ulcerative Colitis- Results of A Survey to Specialized Centers

    Nov 1, 2015, 00:00

  • Using Real-World Hospital Purchasing And Consumption Data To Improve Healthcare Systems Efficiencies

    Nov 1, 2015, 00:00

  • Disease Prevalence and Healthcare Resources Consumption in Patients with Basal Cell Carcinoma in Italian Lhus

    Nov 1, 2015, 00:00

  • Vedolizumab In Crohn’s Disease; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies

    Nov 1, 2015, 00:00

  • Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

    Nov 1, 2015, 00:00

  • Over-Prescription Of Fingolimod In Germany

    Nov 1, 2015, 00:00

  • The german nice or the german nasty? an analysis of iqwig decisions and requirements for an ‘added benefit'

    Nov 1, 2015, 00:00

  • Persistence to Therapy and the Associated Risk of Fractures with Antiosteoporotic Drugs

    Nov 1, 2015, 00:00

  • The Most Profitable Health Insurance “Company” In Turkey

    Nov 1, 2015, 00:00

  • Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine

    Nov 1, 2015, 00:00

  • Prostatectomy- a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques

    Nov 1, 2015, 00:00

  • Safety And Insurance Premium Implications For Hospitals Based On Subcutaneous Versus Intravenous Administration Of Oncology / Hematology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference and Microvascular Complications in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • An Open Label, One Arm Study To Evaluate The Efficacy And Safety of Cerebrolysin In Patients With Acute Severe Ischemic Stroke In Mexico

    Nov 1, 2015, 00:00

  • Do Payers Equally Value the Cost Per Month of Overall Survival for Metastatic Castration Resistant Prostate Cancer within the Eu5?

    Nov 1, 2015, 00:00

  • A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis- Compliant Vs. Non-Compliant Patients

    Nov 1, 2015, 00:00

  • Global Publication Trends in Medical Nutrition Health Economics

    Nov 1, 2015, 00:00

  • Network Meta-Analysis for Health Technology Submissions Worldwide- A Report Checklist for Network Meta Analysis Best Practices Globally

    Nov 1, 2015, 00:00

  • Increasing Transparency and the Patient Voice in HTA of New Medicines

    Nov 1, 2015, 00:00

  • Accessing The Medical Devices Market In Egypt And Saudi Arabia- A Systematic Review Of Policies And Regulations

    Nov 1, 2015, 00:00

  • Reducing Insulin Syringe Reuse Can Help Lower Cost of Insulin Waste In Brazil

    Nov 1, 2015, 00:00

  • Impacto Orçamentário do Everolimo e Sirolimo para Imunossupressão em Transplantados Hepáticos no Sistema Público de Saúde do Brasil

    Nov 1, 2015, 00:00

  • Pharmacoepidemiologic Modeling of Treatment Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabin (Single Tablet Regimen) in Russia

    Nov 1, 2015, 00:00

  • Healthcare Pathways And Burden of Disease of Patients With Inflammatory Bowel Diseases (Ibd)

    Nov 1, 2015, 00:00

  • Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient’s Perspective- Real-World Data

    Nov 1, 2015, 00:00

  • Which Risk Share Agreements are Available and are Those Applied In Global Reimbursement Decisions?

    Nov 1, 2015, 00:00

  • A Novel Itc Approach- Matching Patient-Level Data To Study-Level Summary Means And Variances

    Nov 1, 2015, 00:00

  • Systematic Review And Meta-Analysis of Efficacy And Safety of Simeprevir And Sofosbuvir For Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • Malaria Diagnosis And Treatment Practice Following Introduction of Rapid Diagnostic Test In Selected Health Posts of Adama Woreda, East Shewa Zone, Oromia Region,Centeral Ethiopia

    Nov 1, 2015, 00:00

  • Reduction of Complications and Associated Costs for Type 2 Diabetic Patients Using Continuous Subcutaneous Insulin Infusion In The Uk

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer

    Nov 1, 2015, 00:00

  • Medical Devices For Bandaging And Plasters. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

    Nov 1, 2015, 00:00

  • Migration of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmstm) from Paper to an Electronic Diary Format

    Nov 1, 2015, 00:00

  • Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire

    Nov 1, 2015, 00:00

  • Sq® Hdm Slit-Tablets In Addition To Pharmacotherapy Are Cost-Effective Compared To Pharmacotherapy Only In Treating Patients With Allergic Asthma

    Nov 1, 2015, 00:00

  • Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Neoplasm of Colon

    Nov 1, 2015, 00:00

  • Economic Burden Outcomes In Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • The Impact of Anti-Tnf (Etanercept) Therapy on Work Productivity in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in the Czech Republic

    Nov 1, 2015, 00:00

  • Monitoring Of Critical Laboratory Results To Improve Quality Of Patient Care In A Large Urban Clinic In Uganda

    Nov 1, 2015, 00:00

  • Cost Analysis in Implementing Rituximab for non-Hodgkins Lymphoma - Intravenously and Subcutaneously - in Patients with Social Coverage in Latam

    Nov 1, 2015, 00:00

  • The Economic Burden Of Cardiac Complications Of Percutaneous Coronary Intervention In England- An Analysis Of Hospital Episode Statistics

    Nov 1, 2015, 00:00

  • Tioropium+Olodaterol Respimat; Budget Impact In The Uk

    Nov 1, 2015, 00:00

  • Assocations Between Pain Severity and Quality of Life Domains Among Those Diagnosed With Various Pain Types In Europe

    Nov 1, 2015, 00:00

  • Evaluaci”N De Costo-Efectividad De La Implementaci”N De Monitoreo Ambulatorio De Presi”N Arterial Versus Perfil De Presi”N Arterial Para El Diagn”Stico De Hipertensi”N En El Sistema Público Chileno

    Nov 1, 2015, 00:00

  • Efeitos da Atenção Farmacêutica nos Resultados em Saúde Dos Pacientes- Revisão Sistemática Com Meta-Análises

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated With Non-Valvular Atrial Fibrillation In Italy

    Nov 1, 2015, 00:00

  • In Greece, During 2009-2014, Public Pharmaceutical Expenditure Undoubtedly Fell; But On Whose Backs?

    Nov 1, 2015, 00:00

  • Construction Of Simulation Techniques For Development Of Optimal Cervical Cancer Screening Strategies- Experience Of Ukraine

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 4 Pro Questionnaires for Uterine Fibroids

    Nov 1, 2015, 00:00

  • From Phase Ii Studies to Hta Submissions- Optimal Use of Evidence for Informed Decisions

    Nov 1, 2015, 00:00

  • Análise De Custo-Utilidade Em Pacientes Com Insuficiência Renal Crônica Submetidos À Terapia Renal Substitutiva (Trs)

    Nov 1, 2015, 00:00

  • Implante de Ahmed Versus Implante de Baerveldt- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00

  • Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

    Nov 1, 2015, 00:00

  • A Retrospective, Cross Sectional Study on the Prevalence of Hypertension and Treatment Status in Obese Patients Using a Healthcare Database in Japan

    Nov 1, 2015, 00:00

  • Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the ...

    Nov 1, 2015, 00:00

  • Evolution Of Tiotropium Efficacy Vs. Placebo Over Time For The Maintenance Therapy Of Chronic Obstructive Pulmonary Disease- From Investigational Product To Active Reference

    Nov 1, 2015, 00:00

  • Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure- 1 Year Follow-Up from the Brazilian Public Healthcare System Database

    Nov 1, 2015, 00:00

  • Evaluation of Average Cost-Effectiveness Ratios of Standards of Care Across Different Indications

    Nov 1, 2015, 00:00

  • Anticoagulant Treatment After Vte In The Netherlands

    Nov 1, 2015, 00:00

  • Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients

    Nov 1, 2015, 00:00

  • Estimating Lifetime Medical Costs From Censored Claims Data

    Nov 1, 2015, 00:00

  • Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration- Epidepso Multicentre Study

    Nov 1, 2015, 00:00

  • Patient Access Schemes Within The Uk- A Retrospective Analysis

    Nov 1, 2015, 00:00

  • Assesing The Net Fiscal Consequences Of Tobacco Use In A High Consumption And High Tobacco Tax Country- The Case Of Greece

    Nov 1, 2015, 00:00

  • Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes- a Review of Recently Approved Products

    Nov 1, 2015, 00:00

  • Aspirin Versus Clopidogrel in Patients with Ischemic Stroke- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00

  • Prma Reform in Poland – Impact on Pharmaceutical Industry and Market Access

    Nov 1, 2015, 00:00

  • Patient Utility Estimates In Patients At High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Development of A Precis-2 Scoring Grid- How Pragmatic are Pragmatic Trials of Surgical and Pharmaceutical Interventions?

    Nov 1, 2015, 00:00

  • Efficacy-Effectiveness-Gap – Extent, Causes And Implications

    Nov 1, 2015, 00:00

  • A Real-World Analysis Of Korean Nation-Wide Database- Pattern, Adherence, And Associated Heatlhcare Costs Of Imatinib Among Patients With Chronic Myeloid Leukemia

    Nov 1, 2015, 00:00

  • National Estimates of Prevalence and Patterns of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease in Nursing Home and Home Healthcare Settings in the United States

    Nov 1, 2015, 00:00

  • Examination of Water Consumption- Knowledge About Water Consumption In Population of Bátya And Pécs

    Nov 1, 2015, 00:00

  • Tabagismo Em Universitários- Uma Revisão Sistemática Da Literatura

    Nov 1, 2015, 00:00

  • Translation and Linguistic Validation of the Caregiver Quality of Life Cystic Fibrosis Scale (Cqolcf) and the Multidimensional Scale of Perceived Social Support (Mspss) for use in Germany and the United Kingdom (Uk)

    Nov 1, 2015, 00:00

  • The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals- What are the Impacts For Public Hospitals of Paris ?

    Nov 1, 2015, 00:00

  • Pattern And Factors Associated With Readmission In Patients Hospitalized For Chronic Obstructive Pulmonary Disease In Taiwan

    Nov 1, 2015, 00:00

  • Are Medicines Granted with a Conditional Approval by the European Medicines Agency Gaining Positive Assessment by Payers in France, Germany and the United Kingdom?

    Nov 1, 2015, 00:00

  • Quality Analysis of Pharmacoeconomics Evaluation and Application Literature in China During 2009-2013

    Nov 1, 2015, 00:00

  • Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld

    Nov 1, 2015, 00:00

  • Uptake Of Filgrastim ‘Biosimilars’ In The United States- Analysis Of A Medical Transcription Database Of Patient Office Visits

    Nov 1, 2015, 00:00

  • Cost Analysis of Two Methods for Improving the Quality of Care (Qoc) Scores in Paediatric Hospital Wards During Winter Periods

    Nov 1, 2015, 00:00

  • The Association Between Disease Activity And Indirect Costs of Absenteeism And Presenteeism Generated By Patients With Ankylosing Spondylitis In Polish Population

    Nov 1, 2015, 00:00

  • Finding The Optimal Screening Program For Unknown Atrial Fibrillation Using Simulation Models

    Nov 1, 2015, 00:00

  • The Economic Burden of Brain Disorders In Korea

    Nov 1, 2015, 00:00

  • Treatment Continuation And Treatment Characteristics Of Four Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres, Olanzapine Pamoate And Haloperidol Decanoate) In The Netherlands

    Nov 1, 2015, 00:00

  • Opportunistic Screening For Atrial Fibrillation In Primary Care – A Clinical And Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Differences And Similarities In Hta- A Comparative Analysis Of The Decision-Making Processes For Cancer Drugs Across 4 Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective

    Nov 1, 2015, 00:00

  • Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic

    Nov 1, 2015, 00:00

  • Prevalence of Self-Medication and Its Reason Among Pharmacy Students in India- A cross-sectional study

    Nov 1, 2015, 00:00

  • Resource Use And Direct Costs For Managing Hcv Genotype 1 Patients In Colombia

    Nov 1, 2015, 00:00

  • Treatment Patterns And Budgetary Impact of Chemotherapy Drugs In A Brazilian Private Health Plan (Php)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Phid-Cv Routine Vaccination Programme Compared To Pcv-13 In Portugal

    Nov 1, 2015, 00:00

  • Analysis Of In-Hospital Resource Use After An Ischemic Stroke

    Nov 1, 2015, 00:00

  • A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Trimetazidine In The Management Of Chronic Stable Angina In Greece

    Nov 1, 2015, 00:00

  • The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium

    Nov 1, 2015, 00:00

  • High Therapeutic Efficiency With Ledipasvir/Sofosbuvir For The Treatment Of Genotype 1 Chronic Hepatitis C In Portugal

    Nov 1, 2015, 00:00

  • Effect of Patient-Education on Health-Related Quality of Life of Diabetic Foot Ulcer Patients In A Tertiarycare Hospital

    Nov 1, 2015, 00:00

  • Analysis Of Stroke Statistics In Turkey

    Nov 1, 2015, 00:00

  • Conditional Agreements For Innovative Therapies In Italy- The Case Of Pirfenidone

    Nov 1, 2015, 00:00

  • The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale

    Nov 1, 2015, 00:00

  • Study Of Acute Lower Respiratory Tract Infections In Children Of Age Group 1 Month To 5 Years

    Nov 1, 2015, 00:00

  • Autosomal Polycystic Kidney Disease (Adpkd)- Costs And Resource Utilisation In The Nordic Countries

    Nov 1, 2015, 00:00

  • Value Judgment of Health Interventions From Different Perspectives- Arguments and Criteria

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

    Nov 1, 2015, 00:00

  • High-Cost Oncologic Medication Access- Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2015, 00:00

  • Pricing and Reimbursement Policies of Turkey and Ukraine

    Nov 1, 2015, 00:00

  • Resource Utilisation And Bleeding Events During Anticoagulation Treatment- Real-World Findings From England

    Nov 1, 2015, 00:00

  • The Consequences Of Replacing The Fleischner Guidelines By A Software-Based Volume Doubling Time Technique- An Early-Stage Research

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Romiplostim for The Treatment of Adult Chronic Immune Thrombocytopenic Purpura (Itp) In Brazil

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension

    Nov 1, 2015, 00:00

  • Descripttive Evaluation of Patient Characteristics and Health Care Resource utilization of Patients Diagonsed with Breast Cancer

    Nov 1, 2015, 00:00

  • The Competition Between Drugstore And Primary Care And Treatment Choice Of Patients In The Context Of Essential Medicine Policy In Rural China

    Nov 1, 2015, 00:00

  • Medical Devices- Innovative Models To Access The Market Leveraging On Shared Infrastructure Among Payers And Pharmaceutical Companies

    Nov 1, 2015, 00:00

  • Valuation of Patient Satisfaction With Pharmaceutical Care As A Tool For Increasing Quality Management In Community Pharmacy And Patient’s Quality Of Life

    Nov 1, 2015, 00:00

  • Are vaccines getting a fair deal? Health technology assessment of vaccines across europe

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96 (current)
  • 97
  • 98
  • 99
  • 100
  • »